Male Breast Cancer in the Era of Modern Therapies: Serbian Single Centre Experience Report

PUBLISH – BREAST JOURNAL, © 2014 Wiley Periodicals, Inc., 1075-122X/14 The Breast Journal, 2014 1–2

AUTHORS : Lazar Popovic, MD, Jasna Trifunovic, MD, PhD, Jasna Pesic, MD, Gorana Matovina-Brko, MD, Ivana Kolarov-Bjelobrk, MD, Numa Memisevic, Darjana Jovanovic, MD, PhD,

 Male breast cancer is a rare disease, accounting for less than 1% of total malignant diseases and less than 1% of all breast cancer cases. Inspired by the Ruddy and Winer’s article published in Annals of Oncology, we analyzed our group of patients treated at the Oncology Institute of Vojvodina from 2006 to 2010. We analyzed the medical records of 44 patients managed at our Institute. The median follow-up was 50 months (25–83). Diagnosis was established after radical mastectomy in case of 72% of studied patients; the rest of patients underwent less radical surgery or biopsy in case with primary metastatic disease. Adjuvant radio- and chemotherapy were administered according to standard protocols. The Kaplan–Meier estimator and Mann–Whitney U-test were used for statistical analyses.